P

Inventor

BUNK SEBASTIAN

DE41 patents
⚠️ This page may combine multiple inventors who share the name “BUNK SEBASTIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

IMMATICS BIOTECHNOLOGIES GMBH

38 patents
US10723796B2Jul 28, 2020

T cell receptors and immune therapy using the same

IMMATICS BIOTECHNOLOGIES GMBH22 citations94
US10626160B2Apr 21, 2020

Transfected T-cells and T-cell receptors for use in immunotherapy against cancers

IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US10590194B2Mar 17, 2020

T cell receptors and immune therapy using the same

IMMATICS BIOTECHNOLOGIES GMBH23 citations94
US10550182B2Feb 4, 2020

T cell receptors and immune therapy using the same

IMMATICS BIOTECHNOLOGIES GMBH15 citations94
US10538573B2Jan 21, 2020

Transfected T-cells and T-cell receptors for use in immunotherapy against cancers

IMMATICS BIOTECHNOLOGIES GMBH20 citations94
US10526407B2Jan 7, 2020

T cell receptors and immune therapy using the same

IMMATICS BIOTECHNOLOGIES GMBH17 citations94
US10800832B2Oct 13, 2020

T cell receptors and immune therapy using the same against prame positive cancers

IMMATICS BIOTECHNOLOGIES GMBH19 citations93
US10618956B2Apr 14, 2020

Engineered T cell receptors and immune therapy using the same

IMMATICS BIOTECHNOLOGIES GMBH13 citations93
US11111294B2Sep 7, 2021

T cell receptors and immune therapy using the same

IMMATICS BIOTECHNOLOGIES GMBH11 citations86
US10800845B2Oct 13, 2020

T cell receptors and immune therapy using the same

IMMATICS BIOTECHNOLOGIES GMBH12 citations86
US10725044B2Jul 28, 2020

T cell receptors and immune therapy using the same

IMMATICS BIOTECHNOLOGIES GMBH12 citations86
US10702609B2Jul 7, 2020

T cell receptors and immune therapy using the same

IMMATICS BIOTECHNOLOGIES GMBH14 citations86
US10596242B2Mar 24, 2020

Transfected T-cells and T-cell receptors for use in immunotherapy against cancers

IMMATICS BIOTECHNOLOGIES GMBH12 citations86
US10537624B2Jan 21, 2020

Transfected T-cells and T-cell receptors for use in immunotherapy against cancers

IMMATICS BIOTECHNOLOGIES GMBH15 citations86
US10527623B2Jan 7, 2020

T cell receptors and immune therapy using the same

IMMATICS BIOTECHNOLOGIES GMBH13 citations86
US11072645B2Jul 27, 2021

T cell receptors with improved pairing

IMMATICS BIOTECHNOLOGIES GMBH10 citations85
US10889629B2Jan 12, 2021

Transfected T-cells and T-cell receptors for use in immunotherapy against cancers

IMMATICS BIOTECHNOLOGIES GMBH4 citations73
US10874731B2Dec 29, 2020

T cell receptors and immune therapy using the same

IMMATICS BIOTECHNOLOGIES GMBH4 citations73
US11236145B2Feb 1, 2022

T cell receptors and immune therapy using the same against PRAME positive cancers

IMMATICS BIOTECHNOLOGIES GMBH3 citations72
US11111286B2Sep 7, 2021

T cell receptors and immune therapy using the same against PRAME positive cancers

IMMATICS BIOTECHNOLOGIES GMBH3 citations72
US11104894B2Aug 31, 2021

Method for preparing electrocompetent yeast cells, and method for using said cells

IMMATICS BIOTECHNOLOGIES GMBH3 citations72
US10889645B2Jan 12, 2021

Engineered T cell receptors and immune therapy using the same

IMMATICS BIOTECHNOLOGIES GMBH3 citations72
US10683495B2Jun 16, 2020

Method for preparing electrocompetent yeast cells, and method for using said cells

IMMATICS BIOTECHNOLOGIES GMBH3 citations72
US11840577B2Dec 12, 2023

Antigen binding proteins specifically binding MAGE-A

IMMATICS BIOTECHNOLOGIES GMBH2 citations70
US12297252B2May 13, 2025

T cell receptors with improved pairing

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11998607B2Jun 4, 2024

T cell receptors and immune therapy using the same

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11945854B2Apr 2, 2024

Transfected T-cells and T-cell receptors for use in immunotherapy against cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11939376B2Mar 26, 2024

T cell receptors and immune therapy using the same

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11932689B2Mar 19, 2024

Engineered T cell receptors and immune therapy using the same

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11730796B2Aug 22, 2023

Transfected t-cells and t-cell receptors for use in immunotherapy against cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12269881B2Apr 8, 2025

Antigen binding proteins specifically binding MAGE-A

IMMATICS BIOTECHNOLOGIES GMBH0 citations60
US12570760B2Mar 10, 2026

Antigen binding proteins specifically binding PRAME

IMMATICS BIOTECHNOLOGIES GMBH0 citations58
US12188932B2Jan 7, 2025

Method for high throughput peptide-MHC affinity screening for TCR ligands

IMMATICS BIOTECHNOLOGIES GMBH0 citations58
US11859009B2Jan 2, 2024

Antigen binding proteins specifically binding PRAME

IMMATICS BIOTECHNOLOGIES GMBH0 citations58
US12209137B2Jan 28, 2025

Antigen binding proteins specifically binding CT45

IMMATICS BIOTECHNOLOGIES GMBH0 citations56
US11905328B2Feb 20, 2024

Dual specificity polypeptide molecule

IMMATICS BIOTECHNOLOGIES GMBH0 citations52
US12162940B2Dec 10, 2024

BMA031 antigen binding polypeptides

IMMATICS BIOTECHNOLOGIES GMBH0 citations51
US12480958B2Nov 25, 2025

Method for the characterization of peptide:MHC binding polypeptides

IMMATICS BIOTECHNOLOGIES GMBH0 citations49

BAXALTA INC

2 patents

HEINRICH HEINE UNIVERSITÄT

1 patent